Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease
- 27 March 1999
- journal article
- Published by Elsevier in Brain Research
- Vol. 823 (1-2) , 104-112
- https://doi.org/10.1016/s0006-8993(99)01146-4
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptorPublished by Elsevier ,2004
- Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in JapanAnnals of Neurology, 1998
- gp130, a Shared Signal Transducing Receptor Component for Hematopoietic and Neuropoietic CytokinesJournal of Neurochemistry, 1996
- Increased levels of τ protein in cerebrospinal fluid of patients with alzheimer's disease—correlation with degree of cognitive impairmentAnnals of Neurology, 1995
- Differential shedding of the two subunits of the interleukin‐6 receptorFEBS Letters, 1993
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991
- Molecular cloning and expression of an IL-6 signal transducer, gp130Cell, 1990
- Microtubular reorganization and dendritic growth response in alzheimer's diseaseAnnals of Neurology, 1989
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Estimation of Error Rates in Discriminant AnalysisTechnometrics, 1968